Cochrane Skin Impact Factor increased

The 2022 Cochrane Review Group Impact Factor for the Cochrane Skin Group increased to 9.258

This therefore means that a review published by the Skin Group Skin Group in 2020 and 2021 was cited, on average, 9.2 times in 2022. This represents an increase on the 2021 Impact Factor, which was 7.400. Thank you to all who have contributed!

Congratulations to the authors of the top ten highest-cited reviews for the Skin Group contributing to the 2022 Impact Factor:

Times CitedTitleCD NumberPublication Date
44Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysisCD011535.pub3Jan-20
13Oral H1 antihistamines as 'add-on' therapy to tropical treatment for eczemaCD012167.pub2Jan-19
13Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanomaCD012806.pub2Jul-19
12Interventions to reduce Staphylococcus aureus in the management of eczemaCD003871.pub2Oct-19
11Topical and deviced-based treatments for fungal infections of the toenailsCD012093.pub2Jan-20
10Screening fro reducing morbidity and mortality in malignant melanomaCD012352.pub2Jun-19
8Interventions fro chronic palmoplantar pustulosisCD011628.pub2Jan-20
7Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care sttingsCD011377.pub2Jan-20
7Antistreptococcal interventions for guttate and chronic plaque psoriasisCD011571.pub2Mar-19
7Interventions for chronic pruritus of unknown originCD013128.pub2Jan-20